2VIP

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2008-01-22	Initial release
1.1	2011-05-08		Version format compliance
1.2	2011-07-13		Version format compliance
1.3	2017-07-05		Data collection	diffrn_source
1.4	2024-10-09		Data collection, Database references, Other, Structure summary	chem_comp_atom, chem_comp_bond, database_2, pdbx_database_status, pdbx_entry_details, pdbx_modification_feature	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.